rBCG-FGFR3MUT

N/A

Report date: 2025/01/26 16:07:38

Base Information

Drug NamerBCG-FGFR3MUT
Drug Alias Namebladder cancer vaccine (live attenuated [mycobacterium bovis BCG]) (Manhattan Biosolutions)live-attenuated bacterial vaccine (Manhattan Biosolutions)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionFibroblast growth factor receptor 3 antagonists
TargetsFibroblast growth factor receptor 3
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesManhattan BioSolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesManhattan BioSolutions Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A